Severe 5,10-methylenetetrahydrofolate reductase deficiency: a rare, treatable cause of complicated hereditary spastic paraplegia

被引:16
|
作者
Perna, A. [1 ]
Masciullo, M. [2 ]
Modoni, A. [1 ]
Cellini, E. [3 ]
Parrini, E. [3 ]
Ricci, E. [1 ]
Donati, A. M. [4 ]
Silvestri, G. [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Inst Neurol, Fdn Policlin Gemelli, Lgo Gemelli 8, I-00168 Rome, Italy
[2] IRCSS Santa Lucia, Rome, Italy
[3] A Meyer Childrens Hosp, Lab Neurogenet, Pediat Neurol Unit, Florence, Italy
[4] A Meyer Childrens Hosp, Metab & Neuromuscular Unit, Florence, Italy
关键词
betain; cerebral white matter disease; complicated hereditary spastic paraplegia; hyperhomocysteinemia; severe; 5; 10-methylenetetrahydrofolate reductase deficiency; ADULT;
D O I
10.1111/ene.13557
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purposeJuvenile- or adult-onset forms of severe 5,10-methylenetetrahydrofolate reductase (MTHFR) deficiency manifesting as complicated hereditary spastic paraplegia have rarely been described. MethodsTwo siblings with mental retardation developed a progressive spastic paraparesis in their late teens. Their diagnostic assessment included extensive neurophysiologic, neuroimaging and metabolic studies. ResultsBrain magnetic resonance imaging showed occipital white matter alterations, and electromyography documented a mixed polyneuropathy. Severe hyperhomocisteinemia (>150mol/L) associated with the characteristic amino acid profile suggested a diagnosis of severe MTHFR deficiency, confirmed by MTHFR direct sequencing. Treatment with betaine and vitamins benefitted patients' symptoms and diagnostic features. ConclusionsSevere MTHFR deficiency can be a rare, treatable cause of autosomal recessive complicated hereditary spastic paraplegia. Its screening should be part of the diagnostic flowchart for these disorders.
引用
收藏
页码:602 / 605
页数:4
相关论文
共 50 条
  • [31] Titration of betaine therapy to optimize therapy in an infant with 5,10-methylenetetrahydrofolate reductase deficiency
    Sema Kalkan Ucar
    Özge Altun Koroğlu
    Ömer Berk
    Mehmet Yalaz
    Nilgün Kültürsay
    Henk J. Blom
    Mahmut Coker
    European Journal of Pediatrics, 2010, 169 : 241 - 243
  • [32] 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer
    Li, DH
    Ahmed, M
    Li, YN
    Jiao, L
    Chou, TH
    Wolff, RA
    Lenzi, R
    Evans, DB
    Bondy, ML
    Pisters, PW
    Abbruzzese, JL
    Hassan, MM
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (06) : 1470 - 1476
  • [33] N5,10-METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY AND SCHIZOPHRENIA - WORKING HYPOTHESIS
    MUDD, SH
    FREEMAN, JM
    JOURNAL OF PSYCHIATRIC RESEARCH, 1974, 11 : 259 - 262
  • [34] Cloning and expression of 5,10-methylenetetrahydrofolate reductase (MTHFR) gene
    Chen, GH
    Zhang, CH
    Zhang, XY
    Zhu, YQ
    Tang, J
    Meng, ZH
    Li, Z
    SCIENCE IN CHINA SERIES C-LIFE SCIENCES, 1998, 41 (06): : 636 - 643
  • [35] Cloning and expression of 5,10-Methylenetetrahydrofolate reductase (MTHFR) gene
    陈光慧
    张晨晖
    张霄瑜
    朱燕青
    汤健
    孟昭亨
    李竹
    Science in China(Series C:Life Sciences), 1998, (06) : 636 - 643
  • [36] SCREENING FOR MUTATIONS OF THE HUMAN 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE GENE
    BIGNELL, MK
    SCHWICHTENBERG, KA
    HANSON, NQ
    GARG, UC
    TSAI, MY
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 1003 - 1003
  • [37] Myocardial infarction and 5,10-methylenetetrahydrofolate reductase gene mutation
    Rodrigo, FJR
    Medina, J
    Velásquez, E
    Merino, E
    Delcán, JL
    Guerrero, JE
    REVISTA ESPANOLA DE CARDIOLOGIA, 2004, 57 (05): : 476 - 478
  • [38] Betaine dose and treatment intervals in therapy for homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency
    Sakura, N
    Ono, H
    Nomura, S
    Ueda, H
    Fujita, N
    JOURNAL OF INHERITED METABOLIC DISEASE, 1998, 21 (01) : 84 - 85
  • [39] 5,10-methylenetetrahydrofolate reductase (MTHFR) assay in the forward direction: Residual activity in MTHFR deficiency
    Suormala, T
    Gamse, G
    Fowler, B
    CLINICAL CHEMISTRY, 2002, 48 (06) : 835 - 843
  • [40] A Novel Homozygous Non-sense Mutation in the Catalytic Domain of MTHFR Causes Severe 5,10-Methylenetetrahydrofolate Reductase Deficiency
    Massadeh, Salam
    Umair, Muhammad
    Alaamery, Manal
    Alfadhel, Majid
    FRONTIERS IN NEUROLOGY, 2019, 10